“…Research has shown that LMNA (lamin A/C) [314], VCAM1 [281], MAPK6 [403], DDX3X [366], SHMT2 [459], PHGDH (phosphoglycerate dehydrogenase) [560], S100A9 [433], SNCA (synuclein alpha) [335], TP63 [313], FOSL2 [1449], FHL2 [321], ATF3 [55], FOSL1 [379], DYSF (dysferlin) [475], CA4 [547], S100A8 [58] and MPO (myeloperoxidase) [521] plays an important role in the pathogenesis of lung cancer. LMNA (lamin A/C) [676], VCAM1 [657], DDX3X [708], S100A9 [745], FKBP5 [747], SNCA (synuclein alpha) [690], FOSL2 [1450], FHL2 [680], ATF3 [63], FOSL1 [718], S100A8 [67] and MPO (myeloperoxidase) [787] altered expression is associated with poor prognosis of diabetes mellitus. LMNA (lamin A/C) [676], VCAM1 [986], PHGDH (phosphoglycerate dehydrogenase) [1100], S100A9 [1045], FKBP5 [1046], FHL2 [1003], ATF3 [85] and MPO (myeloperoxidase) [1084] plays an important role in the development of obesity.…”